Search

everythinglearnresearchcommunity

for

Search:↓

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

The compound 4c showed strong potential as an anticancer agent.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Ultrasound-assisted gene therapy could revolutionize tissue regeneration by improving gene delivery.

Severe acne patients have higher inflammatory markers than healthy people.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Targeted cancer therapies often cause serious skin problems that need careful management.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Gray hair can potentially be reversed, leading to new treatments.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Certain drugs can change hair color, either lightening or darkening it.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

New therapies are being developed that target integrin pathways to treat various diseases.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.